Anti-Human CD27 (O323) 65132-1-Ig proteintech

$81.00
In stock
SKU
65132-1-Ig
Catalog No.SizePrice (USD)
65132-1-IG-500UG500 μg$81.00
Catalog Number65132-1-Ig
SynonymsCD27, CD27 antigen, CD27 molecule, CD27L receptor, S152, T cell activation antigen CD27, T14, TNFRSF7, Tp55
HostMouse
ReactivityHuman
Reactivityhuman
FormLiquid
FormulationPBS, Azide
ApplicationsFC
Host / IsotypeMouse / IgG1, kappa
Tested Applications — Positive FC detected inhuman PBMCs
Positive FC detected inhuman PBMCs
Flow Cytometry (FC)FC : 0.5 ug per 10^6 cells in 100 μl suspension
Tested ReactivityHuman
ClassMonoclonal
TypeAntibody
ImmunogenN/A Predict reactive species
Full NameCD27 molecule
Calculated Molecular Weight29 kDa
GenBank Accession NumberBC012160
Gene SymbolCD27
Gene ID (NCBI)939
ENSEMBL Gene IDENSG00000139193
RRIDAB_2918420
ConjugateUnconjugated
Purification MethodAffinity purification
UNIPROT IDP26842
Storage BufferPBS with 0.09% sodium azide, pH 7.3.
Storage ConditionsStore at 2-8°C. Stable for one year after shipment.
FC protocol for CD27 antibody 65132-1-IgDownload protocol
Citations-
IsotypeIgG1, kappa
ClonalityMonoclonal
Clone NumberO323
ConjugationUnconjugated

CD27 (also known as TNFRSF7) is a type I glycoprotein expressed on some B cells and the majority of T cells, and is a member of the tumor necrosis factor (TNF) receptor family. CD27 is required for generation and long-term maintenance of T cell immunity (PMID: 11062504). It is a receptor for CD70 (CD27L). Ligation of CD27 by CD70 induces strong ubiquitination of TRAF and the activation of both canonical and non-canonical NF-kappaB pathways, as well as the JNK pathway (PMID: 19426224). CD27 may also play a role in apoptosis through association with SIVA1. Protocols Product Specific Protocols FC protocol for CD27 antibody 65132-1-Ig Download protocol Standard Protocols Click here to view our Standard Protocols

Product Documents

Datasheet

Reviews

Write Your Own Review
You're reviewing:Anti-Human CD27 (O323) 65132-1-Ig proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.